[Therapeutic effects of macrolides on patients with psoriasis vulgaris, pigmentary prurigo, or eosinophilic pustule folliculitis].
Komiya
N
N
Tamaoki
K
K
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D005499:Folliculitis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011536:Prurigo / Q000188:drug therapy*; D011565:Psoriasis / Q000188:drug therapy*; D015575:Roxithromycin / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D015575:Roxithromycin; D004917:Erythromycin; D017291:Clarithromycin